I can extract side effects

A patient group of more than 600 people, news came out one after another, and it was 99+ in the blink of an eye.

"Have you seen it? Both Novartis and Roche's genetic medicines have reduced their prices. It seems to be a 50% discount."

"It's useless to look at it. A 50% discount will cost several million. I can't afford it."

"This is a good sign. They were very stubborn before and never lowered the price. Now that Sanqing's medicine comes out, the price will drop faster than anyone else."

"I also think that this should be just the beginning. The two major pharmaceutical companies are still testing the market. When Sanqing's drug prices come out, they will probably follow suit and maintain a reasonable market price."

"Hey, these are too far away from me. My family can't afford the 20,000 yuan a year for the medicine. I still think about these things."

"Don't think it's too beautiful. Rensanqing is not a charity organization. All companies want to make money. How low can the price be for you?"

"That's right, this is a one-shot cure, not the kind of medicine that you take every year. Think about Biogen's medicine. A child costs 20,000 yuan a year, and it costs more than one million yuan in a lifetime. This kind of one-time medicine It's not going to be much cheaper."

"Yes, right now, I just don't know how much the Sanqing medicine sells for. My heart is up and down, and I just don't have a bottom line."

"I guess the price won't be known until it's on the market. During this period of time, let's replace it with Biogen's medicine."

"Hey, in fact, I can accept it within 1 million. Anyway, it has cost hundreds of thousands to see a doctor."

"That's you, rich, I'm such a poor ghost, I'll use my head to see a doctor!"

"Sanqing is still very sympathetic to the poor. We don't choose those rich people for clinical trials, but choose those whose families have heavy financial burdens."

"Come on, who has this disease in the family, who doesn't have a heavy burden? If I have money, I will pay for the medicine, and if you are poor, you can get the treatment for free, haha."

"Who told you that your speed is slow and you didn't report your name? It's good to have medicine to buy. Otherwise, if you are so rich, you can buy 14 million injections."

There was a lot of noise in the patient group, and netizens were also discussing, wondering how much Sanqing's gene medicine would sell this time.

*****

Sanqing headquarters, conference room.

Company executives and laboratory directors all gathered together to speak enthusiastically.

Wei Kang spoke first: "As an original rare disease drug, the SMA gene drug has won praise and encouragement from the Food and Drug Administration, so it is eligible to apply for fast-track marketing. It is expected that in two months, the third phase of clinical trials will be completed before it can be launched. gone."

Everyone applauded enthusiastically.

"The launch of this new drug is of great significance, which means that we have made zero breakthroughs in the field of gene therapy. In terms of R\u0026D strength, Sanqing has already reached the level of top international scientific research institutions, and can compete with established pharmaceutical giants. .”

"At present, this aspect is our advantage, especially in China, so today we will discuss the launch price of new drugs, everyone please speak freely."

All the executives at the scene discussed enthusiastically.

"Mr. Wei, our company is still investing a lot of money in researching and developing gene therapy drugs. R\u0026D expenses and clinical expenses are very expensive. The cost of biological drugs is also much more expensive than chemical drugs. We must sell a reasonable one. price."

The chief financial officer was the first to make a suggestion. He was afraid that the boss would lower the price and cause book losses.

Wei Kang nodded, expressing his understanding.

You must know that the research and development of each new drug requires a huge amount of money and manpower.

Pharmaceutical companies invest huge sums of money in the research and development of new drugs every year, and finally achieve results. They must make money in order to form a virtuous circle and continue to overcome various medical terminal diseases.

Sanqing's research and development expenses this year have already exceeded one billion yuan. Recently, it has been recruiting people in various ways, and it is still building the Pangu Research Institute. In general, it has spent a lot of money, which must be included in the cost of medicines.

However, Sanqing is also a special case. Because of the system, the cost of drug research and development is not that high, so he will try his best to give the patients the benefits. However, this kind of thing cannot be stated clearly, as long as you know it in your heart.

And he has always been uncomfortable with some profit-seeking pharmaceutical companies.

These pharmaceutical companies invest a lot in research and development of new drugs, one billion invested, and then the new drugs earn hundreds of billions, but relying on the advantages of their own original drugs, they have not lowered the price, and are still searching for the last of the patients. A little hard-earned money, it can't be justified.

Sanqing cannot be reduced to such a pharmaceutical company, this is Weikang's bottom line.

Not only that, Weikang also wanted to change this situation as much as possible, forcing blood-sucking drug companies to have nowhere to go and had to cut prices.

That's why the domestic prices of the previous anticancer drugs and AD specific drugs are so low.

But this time, he resolutely intends to implement a low-price policy.

After all, most of the patients are babies, and it is only one who can be saved.

The birth rate has gradually decreased every year, and the children born have rare genetic diseases and cannot live for a few years.

He really couldn't just watch these innocent and lovely children die in order to make money.

"I think the price should not be too expensive. It is best to make this drug available to most patients. This is the position of our developers."

To everyone's surprise, Tang Que was the second to speak, and his attitude was extremely firm.

The chief financial officer couldn't help retorting: "That can't deviate too far from the market price, otherwise how will the cost be covered."

Tang Que stared at him with piercing eyes and sneered, "Market price? Now the market price is several million. If you want to sell it at this price, I will be the first to refuse."

"This..." the chief financial officer fell silent.

Tang Que looked around, and added: "If cost was to be considered in the first place, drugs for rare diseases should not be developed."

"Hehe, everyone has something to discuss." Sun Chengren said with a smile: "The cost must be calculated, but the price must not exceed the patient's ability to bear, otherwise the medicine will not be sold."

Chen Yiqing nodded: "I agree with Tang Que on this point. If the medicine cannot be sold because it is too expensive, it is meaningless, and it can only be withdrawn from the market in the end. This must be taken into account when pricing."

"Due to the large number of patients, the research and development of other drugs does not need to consider pricing at all, because the cost will definitely be paid back, but the number of rare patients is too small, and sometimes it can only be used as basic scientific research. I think everyone knows this. .So there is nothing to argue about, the final decision is up to the boss.”

It was rare for Wen Renlong to analyze it seriously, which made everyone nod their heads frequently.

Wei Kang tapped his fingers on the table, pondered for a while, and finally set the tone for this matter.

"The price should not be too expensive or too cheap. It can be compared to the original pricing strategy of anticancer drugs."

Finally, after some discussion, the price was finally settled.

The domestic price is set at 300,000 needles.

The foreign price is also 300,000 needles, but the unit is US dollars.

As for whether to enter the medical insurance, this will have to be negotiated when it goes public.

At this price, everyone felt that Wei Kang was already very conscientious.

After all, the prices of friends and merchants are too expensive, and none of them are less than 1 million. The price of Sanqing is simply broken.

Didn’t you see that Nosinagen Sodium Injection needs 700,000 injections before entering the medical insurance?

It only takes 30,000 injections to enter the medical insurance, which shows that the pricing of pharmaceutical companies is actually quite flexible.

Of course, the price difference is mainly due to medical insurance negotiations, and most of the costs are borne by the huge state institution.

If Sanqing's SMA gene medicine is included in the medical insurance, the price may be even lower, and it will drop to more than 100,000 to 200,000 yuan, which is also a level that most people can afford.

As for foreign patients, there is no need to worry about not getting medical treatment. They also have their own country's medical insurance and commercial insurance to bear part of the cost.

In any case, it is still a lot more cost-effective than Novartis' millions of dollars and Roche's hundreds of thousands of dollars a year.

Generally speaking, it still adheres to the consistent line of collecting money from foreign developed countries to subsidize domestic patients.

Everyone gave thumbs up and praised Wei Kang.

"The boss set the price well."

"Mr. Wei is so grand!"

"The boss is wise and mighty, I am ashamed of myself."

Wei Kang smiled slightly, accepted everyone's flattery, and then concluded: "A gentleman loves money, and he gets it in a proper way."

"For rare disease drugs, the company originally planned not to make money, even if it loses money, it will continue to do so."

"I decided to open another channel for donating medicines for charity. In the future, patients whose families are too poor and really can't afford to buy medicines for treatment can apply for them. After being reviewed, they will get medicines donated by Sanqing."

"In short, we need to make money, but we can't become a black-hearted pharmaceutical company. We can treat diseases and save lives while making money, and help countless families of patients."

After the meeting, Wei Kang came to his office.

As soon as I sat down, I received a call from the executive.

"What? A family member of a patient came to the door? He said he wanted help?"

"Huh? He's a special case? A celebrity?"

Wei Kang was suddenly curious: "Okay, then you arrange to come to the meeting room, and I will meet him."

Before anti-cancer drugs, there seemed to be comments that the price of 100,000 yuan was too expensive. I had no choice but to pay more attention to my health and buy medical insurance as much as possible. Otherwise, is a human life not worth the price of a domestic car? Then I have a little trouble understanding. To be honest, many people in rural areas are not so poor now, and there are quite a few people building buildings to buy cars, so it is unlikely that they cannot afford life-saving money. A six-figure price is not too expensive for a human life. You can’t think of a freshly released life-saving medicine, the price is as cheap as a mobile phone. If this continues, pharmaceutical companies really have no incentive to develop new medicines.